2024-10-18 18:29:54
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy
Corporate/ 2023-07-23
OliX Announces Clinical Candidate Nomina...

SUWON,South Korea,Jan. 18,2019-- OLX10020,a cell-penetrating asymmetric siRNA ("cp-asiRNA") against a novel target (Undisclosed) f...

Stemedica Cell Technologies Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for Ischemic Stroke
Health/ 2023-07-22
Stemedica Cell Technologies Reports Posi...

- itMSCs were safe and well tolerated in the study - - Results of the study are supportive of advancing clinical program -

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release